AIC
TRIL

AWM Investment Company’s Trillium Therapeutics Inc. TRIL Stock Holding History

AWM Investment Company’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-701,138
Closed -$4.07M – 93
2018
Q3 		$4.07M Hold
701,138
– – 0.67% 53
2018
Q2 		$4.21M Sell
701,138
-253,000
-27% -$1.61M 0.7% 48
2018
Q1 		$6.87M Sell
954,138
-15,000
-2% -$114K 1.32% 25
2017
Q4 		$7.08M Sell
969,138
-110,480
-10% -$915K 1.37% 23
2017
Q3 		$5.56M Buy
1,079,618
+76,096
+8% +$358K 0.97% 30
2017
Q2 		$4.42M Buy
+1,003,522
New +$5.55M 0.78% 38

Other funds holding TRIL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AWM Investment Company's TRIL Position: Q4 2018 in Review

AWM Investment Company sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2018, closing a stake of 701,138 shares — an estimated $4.07M sold.

AWM Investment Company first reported a position in TRIL in Q2 2017 and held it in 6 quarters. The position peaked at $7.08M in Q4 2017. 23 funds tracked by Wall St. Rank hold TRIL as of Q4 2018.

  • AWM Investment Company reported no remaining Trillium Therapeutics Inc. position as of Q4 2018 after selling out during the quarter.
  • AWM Investment Company sold 701,138 Trillium Therapeutics Inc. shares in Q4 2018, an estimated $4.07M.
  • AWM Investment Company first reported a position in Trillium Therapeutics Inc. in Q2 2017 and held it in 6 quarters.
  • AWM Investment Company's Trillium Therapeutics Inc. position peaked at $7.08M in Q4 2017.
  • 23 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2018.

Based on AWM Investment Company's 13F filing for Q4 2018, filed 13 Feb 2019.